Skip to content

Clinical trials

Observational Fabry Disease trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fabry Disease Phase: Observational Country / region: Germany Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20071
20081
20103
20112
20121
20141
20172
20181
20201
20211
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting4
Active, not recruiting2
Unknown status2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CENTOGENE GmbH Rostock5
Shire2
Wuerzburg University Hospital2
Chiesi Farmaceutici S.p.A.1
Genzyme, a Sanofi Company1
Johannes Gutenberg University Mainz1
Sangamo Therapeutics1
Takeda1
Technical University of Munich1
University Hospital Heidelberg1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fabry Disease19
Stroke5
Angiokeratoma2
Rare Diseases2
Renal Insufficiency, Chronic2
Cardiomyopathy, Hypertrophic1
Fibrosis1
Hearing Loss1
Mucopolysaccharidoses1
Pregnancy Complications1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.